SYNTIUM

Syntium Pharmaceuticals Inc. is a biopharmaceutical company. Our business model is to in-license early stage candidate drugs (in preclinical or early clinical stages) and to move these down the value chain through clinical development up to Proof-of-Concept in the target patient population. Thereafter, we out-licence these late stage candidate drugs.

Also known as: Syntium Inc.

Primary location: Boston United States